On this page
Overview
Product & regulatory status
FDA-approved prescription products exist for specified male hypogonadism indications.
Slow release, then androgen action
The oil-soluble ester is absorbed from the product and supplies testosterone, which acts through androgen signalling. [1]
What the evidence shows
Why blood-test timing matters
A pharmacokinetic study in 11 hypogonadal men found substantial changes in testosterone and estradiol after cypionate administration. The small study describes fluctuating exposure, not a personalized prediction of energy, mood or sexual function. [2]
Symptom evidence has boundaries
The one-year Testosterone Trials in 790 older men with low testosterone found improved sexual-function measures but no significant primary vitality benefit. These were gel trials, so they do not prove a cypionate-specific advantage. [3]
What remains unknown
No cited comparison establishes cypionate as universally superior to other esters. A serum result alone does not show that fatigue has a testosterone-related cause.
Safety
Blood counts and fertility
Testosterone can increase red-cell production and suppress reproductive-hormone signalling and sperm production. Fertility plans and hematocrit deserve explicit review. [1]
Blood pressure
FDA required class-wide blood-pressure warnings after ambulatory monitoring studies. Replacement therapy still requires risk assessment despite changes to older cardiovascular boxed-warning language. [4]
Product-specific ingredients
The cited cypionate label is an intramuscular cottonseed-oil preparation containing benzyl benzoate and benzyl alcohol. Other products need their own ingredient check. [1]
Understanding product quality
Compounded drugs are not FDA-approved finished products. Poor preparation can cause contamination or incorrect strength. A catalog entry or a research paper is not a quality assessment of your product. [5]
When to seek urgent help
Severe allergic symptoms such as trouble breathing, throat or tongue swelling, or fainting need immediate help. Call 911 or your local emergency number. This is general emergency information, not a complete list of risks for this compound. [6]
A starting point for discussion
This is not a complete list of adverse effects or interactions. Your health history, other medicines, and the exact formulation matter. Missing safety data is not evidence of safety.
Common questions
Is a normal level the only treatment goal?
No. Review the original symptoms, objective benefit and adverse effects alongside the laboratory result.
Why record the exact product?
The ester, concentration, carrier and prescribed route identify the exposure your clinician is interpreting.
Questions for your clinician
Does the evidence match my condition and this exact product? What risks or interactions matter for me? How would we assess whether it is helping?
Sources
- Testosterone cypionate prescribing informationHikma US injection label, updated June 2025; replacement indications, ingredients and adverse effects.
- Nankin: testosterone cypionate hormone kineticsFertility and Sterility, 1987; pharmacokinetic study in 11 hypogonadal men.
- Snyder et al.: Testosterone TrialsNew England Journal of Medicine, 2016; 790 symptomatic men aged 65 or older; testosterone gel versus placebo for one year.
- FDA: testosterone labeling changesFebruary 28, 2025: cardiovascular boxed-warning changes and class-wide blood-pressure warning after TRAVERSE and ambulatory monitoring studies.
- Compounding and the FDA: Questions and AnswersFDA · product quality and regulation
- AnaphylaxisMedlinePlus · recognizing an emergency
Educational information, not a recommendation to use a compound. Kairo does not give dosing advice. Review decisions with a licensed healthcare professional.